Point72 Asset Management
SUPN icon

Point72 Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Point72 Asset Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,318,555
Closed -$68.2M – 4564
2026
Q1 		$68.2M Sell
1,318,555
-946,245
-42% -$48.2M 0.09% 269
2025
Q4 		$113M Buy
2,264,800
+503,316
+29% +$24.5M 0.13% 155
2025
Q3 		$84.2M Buy
1,761,484
+1,253,694
+247% +$50.5M 0.14% 152
2025
Q2 		$16M Buy
507,790
+188,887
+59% +$6.05M 0.03% 577
2025
Q1 		$10.4M Buy
318,903
+292,075
+1,089% +$10.3M 0.02% 669
2024
Q4 		$970K Buy
+26,828
New +$945K ﹤0.01% 1465
2024
Q3 		– Sell
-136,342
Closed -$3.65M – 2326
2024
Q2 		$3.65M Buy
136,342
+8,521
+7% +$247K 0.01% 933
2024
Q1 		$4.36M Buy
+127,821
New +$3.81M 0.01% 1007
2023
Q2 		– Sell
-755
Closed -$27.4K – 2760
2023
Q1 		$27.4K Buy
+755
New +$29K ﹤0.01% 1922
2020
Q2 		– Sell
-346,666
Closed -$6.24M – 1009
2020
Q1 		$6.24M Buy
+346,666
New +$7.28M 0.05% 358
2017
Q1 		– Sell
-1,900
Closed -$48K – 952
2016
Q4 		$48K Buy
+1,900
New +$42.5K ﹤0.01% 665
2016
Q3 		– Sell
-35,600
Closed -$725K – 850
2016
Q2 		$725K Sell
35,600
-909,146
-96% -$16.1M ﹤0.01% 646
2016
Q1 		$14.4M Buy
+944,746
New +$12.3M 0.11% 220

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Point72 Asset Management's SUPN Position: Q2 2026 in Review

Point72 Asset Management sold out of Supernus Pharmaceuticals (SUPN) in Q2 2026, closing a stake of 1,318,555 shares — an estimated $68.2M sold.

Point72 Asset Management first reported a position in SUPN in Q1 2016 and held it in 13 quarters. The position peaked at $113M in Q4 2025. 335 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Point72 Asset Management reported no remaining Supernus Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Point72 Asset Management sold 1,318,555 Supernus Pharmaceuticals shares in Q2 2026, an estimated $68.2M.
  • Point72 Asset Management first reported a position in Supernus Pharmaceuticals in Q1 2016 and held it in 13 quarters.
  • Point72 Asset Management's Supernus Pharmaceuticals position peaked at $113M in Q4 2025.
  • 335 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.